Thermo Fisher on go with Patheon Buy

Thermo Fisher Scientific (NYSE:TMO) has obtained all antitrust clearancesfor its previously announced acquisition of Patheon N.V., including the European Commission who blessed the deal today.

The company plans to finalize the transaction within a week.

Previously: Pantheon up 33% premarket on $7.2B Thermo Fisher bid (May 15)

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.